Proteogenomic Studies Aimed at Understanding Ovarian Tumor Responses to Agents Targeting the DNA Damage Response and Translating this Knowledge into Clinical Benefit

Grant

Date/time Interval

  • June 1, 2017 - May 31, 2019
  • Total Award Amount

  • 273443.00
  • Direct Costs

  • 184137.00
  • Sponsor Award Id

  • 0000911776
  • Contributor

  • Birrer M.D., Ph.D. M.D., Ph.D., Michael J.   Principal Investigator